Navigation Links
2012 Pharmaceutical Diversification Trends, Egypt & Saudi Arabia Pharmaceutical Markets Analyzed in New Research Reports
Date:6/28/2012

Egypt has certain key differences from many other markets. For example, the data protection period for drugs is five years from when the registration application is filed, rather than from the date of market authorization.

Request A Sample, Inquire before buying or Buy your copy of this report @http://www.reportsnreports.com/reports/169855-the-pharmaceutical-market-in-egypt.html.

C.  The Pharmaceutical Market in Saudi Arabia

The report forecasts the Saudi Arabian pharmaceutical market to 2017, set in the context of its macroeconomic environment and healthcare system. Regulatory systems, distribution networks, and pricing and reimbursement arrangements are examined in detail. The report also provides profiles of the leading companies, incorporating their product portfolios and growth strategies in Saudi Arabia.

Features and benefits

  • Plan your company's strategy for Saudi Arabia by assessing factors driving and restraining market growth.
  • Understand the dynamics between innovative drugs and generics and how this could affect your business plan.
  • Forecast the market to 2017, with separate coverage of generic and patented markets.
  • Assess which multinational companies already have a strong market presence and gain valuable insight from their success.
  • Develop an understanding of the intellectual property and regulatory environment and how these can affect your product launch strategy.

Highlights

Saudi Arabia has a national health system which provides free healthcare services to all Saudi citizens and expatriates working in the public sector.

In addition to receiving pricing advantages, the local generics industry is supported by the government through incentives of free land, interest-free loans and a 10% subsidy to the production cost of medicines and pharmaceutical products. Pharmacoeconomic assessments are being phase in to inform approval and pricing decisions.

Drivers of drug volume demand will be an increasing and aging population, as well as the rising prevalence of major civilization diseases such as diabetes and cardiovascular problems, which require long-term treatment.

Request A Sample, Inquire before buying or Buy your copy of this report @ http://www.reportsnreports.com/reports/169857-the-pharmaceutical-market-in-saudi-arabia.html.

More Pharmaceutical Market Research Reports @ http://www.reportsnreports.com/market-research/pharmaceuticals/.

Find newly published market research reports for other industries @http://www.reportsnreports.com/latest-market-research.aspx.

About Us:

ReportsnReports.com (http://www.reportsnreports.com/) is an online market research reports library of 175,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Contact:
Priyank Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
sales@reportsandreports.com
Explore Company Profiles, SWOT Analysis Reports, Micro Markets & Country specific reports @ http://www.marketreportsonline.com/.



'/>"/>
SOURCE ReportsnReports
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , Mar. 29, 2017 Research and ... Systems Market 2014 - 2025" report to their offering. ... ... USD 303.7 million by 2025. Increasing geriatric population prone to ... for orthopedic navigation systems over the forecast period. Osteoarthritis and ...
(Date:3/29/2017)... March 29, 2017  The Global Health Innovative ... partnership formed to battle infectious diseases around the ... million* that could help deliver a range of ... conditions. This latest round of ... clinical trial testing a pediatric formulation of a ...
(Date:3/29/2017)... BEACH, Calif. , March 29, 2017 /PRNewswire/ ... have recognized remote monitoring devices like  Soberlink Systems ...   The consensus paper, published in early 2017, ... practical and valuable in managing patient recovery." ... in the Journal of Addiction Medicine, detail a ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower program in 2009 ... have participated in the program every summer. The 2017 Serve, Learn, & Empower ... Visit http://www.ghana.yfiexperience.org to learn more. , “I have sent my daughter ...
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis ... Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved ... states. Ingredients in HeartBoost, an over the counter heart healthy drink, can reduce ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... Dr. Angela ... early orthodontic treatment and accepting new pediatric patients, with or without a referral. Dr. ... patients have a better orthodontic outcome and experience. When patients receive early treatment, they ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a premium ... finalization of the company’s executive management team with prominent executives from both inside and ... Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty years ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
Breaking Medicine News(10 mins):